Видео ютуба по тегу Covaxin Trial

Covaxin phase-3 trial will begin as second trial has successful results | India | Corona Vaccine
Covaxin phase-3 trial will begin as second trial has successful results | India | Corona Vaccine
Covid update: Covaxin phase 3 trial; China locks down Hebei; UK vaccine supply
Covid update: Covaxin phase 3 trial; China locks down Hebei; UK vaccine supply
India’s Covid cases cross 1.1 million, AIIMS to start Covaxin trial this week
India’s Covid cases cross 1.1 million, AIIMS to start Covaxin trial this week
Covaxin trial data: Bharat Biotech vaccine shows 77.8% overall efficacy, 65% against Delta variant
Covaxin trial data: Bharat Biotech vaccine shows 77.8% overall efficacy, 65% against Delta variant
India’s First COVID-19 Vaccine Candidate COVAXIN To Begin Human Trials In July | Big Story
India’s First COVID-19 Vaccine Candidate COVAXIN To Begin Human Trials In July | Big Story
COVID Vaccine Trials: AIIMS gives a nod for human trial of Covaxin
COVID Vaccine Trials: AIIMS gives a nod for human trial of Covaxin
Covid Vaccine: India Today Reporter Kumar Abhishek Shares Experience After Covaxin Trial shot
Covid Vaccine: India Today Reporter Kumar Abhishek Shares Experience After Covaxin Trial shot
COVID-19 Vaccine: India’s COVAXIN gets DCGI approval for human clinical trials | Covaxin India
COVID-19 Vaccine: India’s COVAXIN gets DCGI approval for human clinical trials | Covaxin India
Bharat Biotech Concludes Phase 3 trial Of Covaxin Records 77.8% Efficacy Rate
Bharat Biotech Concludes Phase 3 trial Of Covaxin Records 77.8% Efficacy Rate
Coronavirus Updates: Phase 2 Trial Of Covaxin To Begin In September
Coronavirus Updates: Phase 2 Trial Of Covaxin To Begin In September
Covid-19 Vaccine: Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today
Covid-19 Vaccine: Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today
Covaxin Can Be Taken Off
Covaxin Can Be Taken Off "Clinical Trial Mode", Expert Panel Recommends
Covid update: Karnataka suspends vaccination for 18-44 age; Covaxin trial nod
Covid update: Karnataka suspends vaccination for 18-44 age; Covaxin trial nod
Covaxin, India’s First COVID-19 Vaccine, Cleared For Phase 3 Human Trial
Covaxin, India’s First COVID-19 Vaccine, Cleared For Phase 3 Human Trial
Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
Phase III Trials Of Bharat Biotech's Covaxin | CNBC-TV18
Phase III Trials Of Bharat Biotech's Covaxin | CNBC-TV18
Headlines: Covaxin 77.8% Effective Against Coronavirus In Phase 3 Trial, Says Bharat Biotech
Headlines: Covaxin 77.8% Effective Against Coronavirus In Phase 3 Trial, Says Bharat Biotech
‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results
‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results
Headlines: Expert Panel Recommends Covaxin Trial On Children Aged 2-18 Years
Headlines: Expert Panel Recommends Covaxin Trial On Children Aged 2-18 Years
Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid
Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid